ConductScience.org, home

Paper12778

Pharmacological basis for antihypertensive effects of intravenous labetalol.

Richards DA and 4 others. Br Heart J, 1977. Cited by 89 papers, by iCite.

Cite this record

ConductScience Library. Pharmacological basis for antihypertensive effects of intravenous labetalol. Papers, record 12778. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12778

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacological basis for antihypertensive effects of intravenous labetalol.
PubMed
Journal
Br Heart J
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
89
iCite
Relative citation ratio, by iCite
5.32
iCite
Revised in PubMed
2019-05-03
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Richards DAD A
2Prichard BNB N
3Boakes AJA J
4Tuckman JJ
5Knight EJE J

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antihypertensive AgentsMajor topic
EthanolaminesMajor topic
LabetalolMajor topic
Adrenergic alpha-Antagonists
Adult
Blood Pressure
Depression, Chemical
Dose-Response Relationship, Drug
Heart Rate
Humans
Isoproterenol
Male
Phenylephrine
Physical Exertion

Source PubMed

Download CSV of topics

References8

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110953Intravenous labetalol in hypertensive patients treated with beta-adrenoreceptor-blocking drugs.Br J Clin Pharmacol1976https://conductscience.org/library/papers/10953PubMed
214089056A SPHYGMOMANOMETER FOR EPIDEMIOLOGISTS.Lancet1964https://conductscience.org/library/papers/14089056PubMed
34404413Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors.Br J Pharmacol1972https://conductscience.org/library/papers/4404413PubMed
49968Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol.Br J Clin Pharmacol1976https://conductscience.org/library/papers/9968PubMed
5791328Haemodynamic effects of long-term oral labetalol.Br J Clin Pharmacol1976https://conductscience.org/library/papers/791328PubMed
6973955Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drug.Br J Clin Pharmacol1976https://conductscience.org/library/papers/973955PubMed
7973959beta-Adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers.Br J Clin Pharmacol1976https://conductscience.org/library/papers/973959PubMed
853581Letter: Intravenous labetalol in severe hypertension.Lancet1975https://conductscience.org/library/papers/53581PubMed

Download CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 89 citations.

PMIDTitleJournalYearIn PapersSource
28197344From Bad to Worse: Paraganglioma Diagnosis during Induction of Labor for Coexisting Preeclampsia.Case Rep Anesthesiol2017https://conductscience.org/library/papers/28197344PubMed
26495054Efficacy of intraoperative dexmedetomidine infusion on visualization of the surgical field in endoscopic sinus surgery.Korean J Anesthesiol2015https://conductscience.org/library/papers/26495054PubMed
8527263The dose dependency of the alpha- and beta-adrenoceptor antagonist activity of carvedilol in man.Br J Clin Pharmacol1995https://conductscience.org/library/papers/8527263PubMed
7308279The electrophysiological effects of intravenous labetalol in man.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/7308279PubMed
7093094Alternatives to beta-blockade in therapy of hypertension with angina pectoris: role of nifedipine or of labetalol.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7093094PubMed
6988003Comparison of labetalol and propranolol in hypertension.Br J Clin Pharmacol1980https://conductscience.org/library/papers/6988003PubMed
6882628Magnitude and mechanisms of the antihypertensive action of labetalol, including ambulatory assessment.Br J Clin Pharmacol1983https://conductscience.org/library/papers/6882628PubMed
6370541Clinical pharmacokinetics of labetalol.Clin Pharmacokinet1984https://conductscience.org/library/papers/6370541PubMed
6310204Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension.Klin Wochenschr1983https://conductscience.org/library/papers/6310204PubMed
6151889Pharmacology of combined alpha-beta-blockade. I.Drugs1984https://conductscience.org/library/papers/6151889PubMed
3917674Oral labetalol in the management of stable angina pectoris in normotensive patients.Br Heart J1985https://conductscience.org/library/papers/3917674PubMed
3889356Propranolol versus labetalol: interesting differences in efficacy.J Natl Med Assoc1985https://conductscience.org/library/papers/3889356PubMed
3154919Role of vasodilation in the antihypertensive and antianginal effects of labetalol: implications for therapy of combined hypertension and angina.Cardiovasc Drugs Ther1988https://conductscience.org/library/papers/3154919PubMed
2908732Properties of labetalol, a combined alpha- and beta-blocking agent, relevant to the treatment of myocardial ischemia.Cardiovasc Drugs Ther1988https://conductscience.org/library/papers/2908732PubMed
2663413Labetalol. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in hypertension and ischaemic heart disease.Drugs1989https://conductscience.org/library/papers/2663413PubMed
2565523The management of acute poisoning due to beta-adrenoceptor antagonists.Med Toxicol Adverse Drug Exp1989https://conductscience.org/library/papers/2565523PubMed
1884570Clinical pharmacokinetics and kinetic-dynamic relationships of dilevalol and labetalol.Clin Pharmacokinet1991https://conductscience.org/library/papers/1884570PubMed
43165Clinical pharmacology of labetalol.Br J Clin Pharmacol1979https://conductscience.org/library/papers/43165PubMed
26370The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.Br J Clin Pharmacol1978https://conductscience.org/library/papers/26370PubMed
25757Labetalol: a review of its pharmacology and therapeutic use in hypertension.Drugs1978https://conductscience.org/library/papers/25757PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12778

GET https://conductscience.org/api/papers/v1/12778/authors